| titleOfInvention |
Glp-2 peptide, polynucleotide construct, host cell, glp-2 derivative comprising a glp-2 peptide, pharmaceutical composition, use of a glp-2 derivative, method for treating intestinal insufficiency or other condition leading to malfunction nutrient absorption in the intestine, method for treating diseases, and method for producing glp-2 peptide |
| abstract |
"GLP-2 PEPTIDE, POLYNUCLEOTIDE CONSTRUCTION, HOST CELL, GLP-2 DERIVATIVE UNDERSTANDING A GLP-2 PEPTIDE, PHARMACEUTICAL COMPOSITION, USE OF A GLP-2 DERIVATE FOR INSTATIONAL INSTATORY OR INSTATORY TRACT Poor NUTRIENT ABSORPTION IN THE GUT, METHOD FOR TREATMENT OF DISEASES, AND METHOD FOR PRODUCING GLP-2 PEPTIDE ". The present invention relates to novel human glucagon-like peptide-2 (GLP-2) peptides and glucagon-like peptide-2 derivatives that have a protracted action profile as well as to the polynucleotide constructs encoding such peptides. vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment. |